Robert Baffi - 20 Feb 2026 Form 4 Insider Report for Neurogene Inc. (NGNE)

Reporting relationship: Director
Issuer ticker: NGNE
Reported as of: 20 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Feb 2026, 18:41:39 UTC
Prior SEC filing: 13 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Donna M. Cochener as attorney-in-fact for Robert Baffi

Key filing fact

Robert Baffi filed Form 4 for Neurogene Inc. (NGNE) on 24 Feb 2026.

Key facts

This page summarizes Robert Baffi's Form 4 filing for Neurogene Inc. (NGNE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 24 Feb 2026, 18:41.

Change

Previous filing in this sequence was filed on 13 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001274826 Primary reporting owner

BAFFI ROBERT

Relationship: Director
Address: C/O NEUROGENE INC., 535 W 24TH STREET, 5TH FLOOR, NEW YORK
Signature: /s/ Donna M. Cochener as attorney-in-fact for Robert Baffi
Signature date: 24 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NGNE transaction Derivative

Non-Qualified Stock Option (right to buy)

Award

Transaction value: $0
Shares: +12,050
Change %
Price: $0.000000
Shares after: 12,050
Date: 20 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,050
Exercise price: $17.64
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests as to 1/12 of the total shares monthly beginning March 20, 2026 until the option is fully vested on February 20, 2027, subject to the Reporting Person's provision of service to the Issuer on each vesting date.